Part of situation:
Biopharma financing and deals 2026 (22 clusters)
Crescita files circular for special meeting and interim order in ClinActiv arrangement
LAVAL, Quebec — Crescita Therapeutics Inc. (TSX: CTX; OTC US: CRRTF) announced that it has filed and mailed the management information circular and related materials for a special meeting of its shareholders to be held on May 14, 2026 in person, in connection with an arrangement with ClinActiv Holdings.
The company also disclosed that it has received an interim order in respect of the ClinActiv arrangement, and that the Circular and related materials have been mailed to shareholders as part of the meeting process.
Sources
Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026
[financialpost.com]
3 months ago
Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026
[montrealgazette.com]
3 months ago